Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 24OTHER_GOV 3NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 2Stomach Neoplasms 1Pancreatic Neoplasms 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1

Interventions

Fluorouracil 74Leucovorin 48Oxaliplatin 44Cisplatin 40Capecitabine 39Gemcitabine 37Radiotherapy 30Irinotecan 28Cetuximab 21Paclitaxel 15Bevacizumab 12Docetaxel 10Taxes 9durvalumab 8dehydroftorafur 8Surgical Procedures, Operative 8Mitomycin 8Specimen Handling 7Platinum 7Folfox protocol 7Carboplatin 7Albumin-Bound Paclitaxel 7130-nm albumin-bound paclitaxel 7S 1 (combination) 6Panitumumab 6Watchful Waiting 5Imatinib Mesylate 5Gene Expression Profiling 5Epirubicin 5tremelimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Preoperative Exercise × Gastrointestinal × Clear all
NCT06976710 2026-05-20

PC2

Surgical Outcomes Research Centre (SOuRCe)

Phase NA Recruiting
564 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06212700 2024-04-25

PRIORITY-CONNECT 2 Pilot Trial

Surgical Outcomes Research Centre (SOuRCe)

Phase NA Unknown
20 enrolled
Gastrointestinal

Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡